Large-scale Manufacturing-Anrate's focus on genetic modification has led to significant advancements in recombinant protein expression efficiency, impurity reduction, and protein folding optimization. With a comprehensive engineering chassis cell bank and precise purification solutions, we ensure consistency across various recombinant protein production processes. Moreover, our cutting-edge albumin biopharmaceutical super-smart factory exemplifies our commitment to design optimization, efficiency enhancement, intelligent upgrading, and industrialization.
New Drug Development-Building on our robust albumin production capabilities, Anrate has established an expanded platform to continuously drive the development of innovative drugs. We cater to the diverse needs of biomedical companies in research and development, pilot testing, and commercial production, covering all critical stages such as target preparation, antibody screening, antibody optimization, and antibody evaluation. We provide comprehensive and meticulous solutions tailored to the needs of antibody screening and optimization for different species.
Pharmaceutical Excipients-Anrate specializes in providing high-quality, differentiated protein pharmaceutical excipients to biomedical companies. Through deep cooperation with enterprises, universities, and research institutions, we develop high-end pharmaceutical excipients with independent intellectual property rights and enjoy independent invention rights. This fulfills the varying needs of biomedical companies in research and development, pilot testing, and commercial production, supporting continuous innovation in the pharmaceutical industry and serving as an important driver for its development.
Cell Culture Media-Anrate aims to become the world's largest producer of serum-free cell culture media, offering innovative solutions tailored to diverse research applications. Our serum-free media, utilizing recombinant human albumin, ensure high batch consistency, safety, and reproducibility, effectively supporting cell culture growth and function while minimizing batch-to-batch variations associated with traditional serum-based media.
中文